🇺🇸 FDA
Patent

US 11926826

Twist signaling inhibitor compositions and methods of using the same

granted A61KA61K47/6923

Quick answer

US patent 11926826 (Twist signaling inhibitor compositions and methods of using the same) held by The Regents of the University of California expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K47/6923